Roadmap to Parenthood: Testing the Efficacy of a Decision Aid and Planning Tool for Family Building After Cancer

Description

This study will test a decision support intervention that consists of a web-based 'decision aid and planning tool' for family building after cancer in a randomized controlled trial.

Conditions

Quality of Life, Parenthood Status

Talk to us

Study Overview

On this page

Study Details

Study overview

This study will test a decision support intervention that consists of a web-based 'decision aid and planning tool' for family building after cancer in a randomized controlled trial.

Roadmap to Parenthood: Testing the Efficacy of a Decision Aid and Planning Tool for Family Building After Cancer

Roadmap to Parenthood: Testing the Efficacy of a Decision Aid and Planning Tool for Family Building After Cancer

Condition
Quality of Life
Intervention / Treatment

-

Contacts and Locations

Palo Alto

Stanford Universtiy, Palo Alto, California, United States, 94305

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Assigned female at birth
  • * Aged 18 to 45 years old
  • * Understands verbal and written English
  • * History of a cancer diagnosis.
  • * Completed cancer treatment(s) with known or uncertain gonadotoxic effects (e.g., systemic chemotherapy, surgery or radiation affecting reproductive organs or hormone regulation, stem cell or bone marrow transplant, and/or immunotherapy)
  • * Interested in having a future child (or more children) or uncertain about family building plans
  • * Access to the Internet and use of a computer, tablet, or smartphone
  • * Ability to understand and the willingness to personally sign the written IRB-approved informed consent document
  • * Currently undergoing cancer treatment excluding long term adjuvant or maintenance therapies, such as tamoxifen
  • * Significant physical or mental disability that prevents completion of study activities

Ages Eligible for Study

18 Years to 45 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Stanford University,

Catherine Benedict, PhD, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

2028-07-31